市場調查報告書
商品編碼
1372540
美國數位藥局市場規模和預測(2020-2030)、區域佔有率、趨勢和成長機會分析範圍:按藥物類型(處方藥和非處方藥)、產品、平台和性別(男性和女性)US Digital Pharmacy Market Size and Forecast (2020-2030), Regional Share, Trends, and Growth Opportunity Analysis Coverage: by Drug Type (Prescription Medicine and Over-the-Counter Medicine), Product, Platform, and Gender (Male and Female) |
美國數位藥局市場預計將從2022年的672.42億美元成長到2030年的2,402.16億美元;預計2022年至2030年年複合成長率為17.25%。COVID-19大流行期間線上購買處方藥的激增以及對線上平台的日益青睞是推動美國數字藥房市場成長的幾個因素。
監測血糖是糖尿病管理的重要組成部分。血糖儀或血糖儀通常用於血糖監測。它涉及採集一小滴血,通常是刺破指尖並將其放在血糖儀的試紙上。血糖值以毫克每分升 (mg/dl) 為單位測量,安全血糖的標準指引範圍為 70 至 180 mg/dl。
COVID-19 大流行期間線上購買處方藥的激增推動了美國數位藥房市場
根據 ASOP 全球基金會 2020 年發布的報告,由於便利性和成本效益,近 50% 的美國人口在網路上購買藥品。 Abacus Data 對1,500 名美國消費者進行的另一項調查顯示,2020 年,十分之四的美國人(42%) 在網上購買藥品,從2020 年到2021 年,網上購買藥品的人數增加了7 %。此外,購買趨勢美國表示,美國人在網上購買一系列處方藥,範圍從治療慢性和持續性疾病的產品(佔所有購買量的23%),包括高血壓、哮喘和糖尿病,到癌症和激素替代療法藥物等專業處方藥(每項均佔所有購買量的 11%)。此外,64%的人在2021年首次在網路上購買藥品,並打算在疫情結束後繼續在網路上購買藥品。人們對網上購買藥品的偏好主要是因為購買的便利性、產品的可及性以及處方藥成本的降低(折扣、特價等)。 According to a survey conducted by healthinsurance.com, there was a 340% increase in telemedicine usage among Medicare recipients in the US in 2021. 33% of the increased users revealed that they preferred ordering prescription medicines through an online pharmacy during the COVID-19大流行.因此,數位藥劑師數量的增加以及處方藥的線上購買,再加上電子商務行業的迅速發展以及消費者行為向線上購買的大規模轉變,有利於美國數位藥房市場的成長。
市場趨勢
基於網路的整合線上藥局介面成為主要趨勢
整合電子醫療保健系統與藥劑師和患者可以訪問的基於網路的藥房介面相結合,可能會成為未來幾年美國數位藥房市場的新趨勢。線上藥局為購買藥品的人提供線上支援的程式就是此類介面的一個顯著例子。例如,服用他汀類藥物作為治療的一部分的患者可能會停止服藥或出現服藥不規則的情況。與接受過培訓的藥房團隊成員進行提醒和即時聊天,為服用他汀類處方藥的人提供依從性支持,可以幫助避免停藥。
基於平台的見解
從平台來看,美國數位藥局市場分為應用程式平台和網站平台。基於應用程式的應用程式進一步細分為遠距醫療藥房應用程式、藥物管理應用程式、健康和保健應用程式、複合藥房應用程式等。基於應用程式的細分市場將在 2022 年佔據更大的市場佔有率,預計該細分市場在預測期內的年複合成長率將達到 17.60%。預計 2022 年至 2030 年期間,遠距醫療藥房應用程式將佔據基於應用程式細分市場的最大佔有率。可以從任何地方透過遠距醫療應用程式存取虛擬醫療保健。根據 CDC 2021 年發布的資料,2020 年有 37.0% 的成年人使用遠距醫療,包括醫療服務提供者就診、線上處方和心理健康服務。最好的遠距醫療應用程式可以免費下載並且易於使用,而且它們通常完全涵蓋保險服務。遠距醫療藥局應用程式的一些範例包括 Hims & Hers、GoodRx、K Health 和 Doctor on Demand。 GoodRx 提供低成本就診、透過電子郵件輕鬆補充處方以及無需健康保險的就診等服務。
根據藥品類型,美國數位藥局市場分為處方藥和非處方藥。處方藥細分市場將在 2022 年佔據更大的市場佔有率,預計該細分市場在預測期內的年複合成長率將達到 17.83%。根據產品,美國數位藥局市場分為個人護理、維生素和補充劑、藥物和治療以及其他產品。藥物和治療領域進一步分為性健康、神經系統疾病、心臟保健、糖尿病、減重等。藥物和治療領域在 2022 年佔據了更大的市場佔有率,預計該領域在預測期內的年複合成長率將達到 17.87%。從平台來看,美國數位藥局市場分為應用程式平台和網站平台。基於應用程式的應用程式進一步細分為遠距醫療藥房應用程式、藥物管理應用程式、健康和保健應用程式、複合藥房應用程式等。基於應用程式的細分市場將在 2022 年佔據更大的市場佔有率,預計該細分市場在預測期內的年複合成長率將達到 17.60%。按性別分類,市場分為男性和女性。到 2022 年,女性細分市場將佔據更大的市場佔有率,預計該細分市場在預測期內的年複合成長率將達到 17.64%。
The US digital pharmacy market is expected to grow from US$ 67.242 billion in 2022 to US$ 240.216 billion by 2030; it is expected to grow at a CAGR of 17.25% from 2022 to 2030. Upsurge in online purchase of prescription medicines during the COVID-19 pandemic and an increasing inclination toward online platforms are a few factors driving the US digital pharmacy market growth.
Monitoring blood sugar is a vital part of diabetes management. A glucometer or blood sugar meter is commonly used for blood glucose monitoring. It involves taking a small drop of blood, usually by pricking the fingertip and placing it on the test strip in a glucometer. Blood sugar levels are measured in milligrams per deciliter (mg/dl), with standard guidelines for safe blood sugar ranging from 70 to 180 mg/dl.
Upsurge in Online Purchase of Prescription Medicines During COVID-19 Pandemic Propels US Digital Pharmacy Market
According to a report published by the ASOP Global Foundation in 2020, nearly 50% of the American population purchased medicines online due to convenience and cost benefits. As per another survey conducted by Abacus Data on 1,500 American consumers, 4 in 10 Americans (42%) purchased medicines online in 2020, recording a 7% rise in the number of online buyers of medicines from 2020 to 2021. Moreover, purchase trends in the US indicate Americans buy an array of prescription drugs online, ranging from products prescribed against chronic and ongoing conditions (23% for all purchases), including high blood pressure, asthma, and diabetes, to specialty prescriptions such as cancer and hormone replacement therapy drugs (each accounting 11% of all purchases). Additionally, 64% of the individuals purchased medicines online for the first time in 2021, with intentions to continue buying online medicine even after the pandemic ends. The preference for online buying of medicines is mainly due to the convenience of buying, accessibility to products, and reduced cost of prescription medication (discounts, special offers, etc.). According to a survey conducted by healthinsurance.com, there was a 340% increase in telemedicine usage among Medicare recipients in the US in 2021. 33% of the increased users revealed that they preferred ordering prescription medicines through an online pharmacy during the COVID-19 pandemic. Thus, an increase in the number of digital pharmacists along with online purchases of prescription medicines, coupled with the rapidly spurring e-commerce industry and a massive shift in consumer behavior toward online purchases, favors the US digital pharmacy market growth.
Market Trend
Integrated Web-Based Online Pharmacy Interface Emerges as Key Trend
Integrated e-healthcare systems incorporated with web-based pharmacy interfaces that are accessible to pharmacists and patients are likely to emerge as new trends in the US digital pharmacy market in the coming years. Programs made available by online pharmacies to provide online support to people buying medicines are a notable example of such interfaces. For instance, patients administered with statins as a part of their treatments are likely to discontinue or show irregularities in taking medicines. Reminders and live chat with a pharmacy team member trained in providing adherence support to people consuming statin-based prescribed medicines can help avoid the discontinuation of doses.
Platform-Based Insights
In terms of platform, the US digital pharmacy market is categorized into app-based and website-based. The app-based is further segmented into telehealth pharmacy apps, medication management apps, health and wellness apps, compounding pharmacy apps, and others. The app-based segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR of 17.60% during the forecast period. Telehealth pharmacy apps are expected to account for a maximum share of the market for the app-based segment during 2022-2030. Virtual healthcare can be accessed through telehealth apps from anywhere. According to CDC data published in 2021, 37.0% of adults used telemedicine in 2020, including provider visits, online prescriptions, and mental health services. The best telehealth apps can be downloaded free of cost and are easy to use, and they often completely cover insurance services. A few examples of telehealth pharmacy apps are Hims & Hers, GoodRx, K Health, and Doctor on Demand. GoodRx offers services such as low-cost visits, easy prescription refills via mail, and visits without health insurance.
Based on drug type, the US digital pharmacy market is bifurcated into prescription medicine and over-the-counter medicine. The prescription medicine segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR of 17.83% during the forecast period. Based on product, the US digital pharmacy market is segmented into personal care, vitamins & supplements, medicines & treatments, and other products. The medicine & treatments segment is further segregated as sexual health, neurological disorders, heartcare, diabetes, weight loss, and others. The medicine and treatment segment held a larger market share in 2022, and the segment is anticipated to register a higher CAGR of 17.87% during the forecast period. In terms of platform, the US digital pharmacy market is categorized into app-based and website-based. The app-based is further segmented into telehealth pharmacy apps, medication management apps, health and wellness apps, compounding pharmacy apps, and others. The app-based segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR of 17.60% during the forecast period. By gender, the market is bifurcated into males and females. The females segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR of 17.64% during the forecast period..